These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8782744)

  • 21. The T-cell repertoire for antigen and MHC.
    Marrack P; Kappler J
    Immunol Today; 1988 Oct; 9(10):308-15. PubMed ID: 3076400
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of an indirectly presented epitope in a mouse model of skin allograft rejection.
    MacEachern MC; Burkhart C; Lowrey PA; Wraith DC
    Transplantation; 1998 May; 65(10):1357-64. PubMed ID: 9625019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation.
    Popov IA; Fedoseyeva EV; Orr PL; Garovoy MR; Benichou G
    Transplantation; 1995 Dec; 60(12):1621-4. PubMed ID: 8545902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
    Liu Z; Colovai AI; Tugulea S; Reed EF; Fisher PE; Mancini D; Rose EA; Cortesini R; Michler RE; Suciu-Foca N
    J Clin Invest; 1996 Sep; 98(5):1150-7. PubMed ID: 8787678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of alloimmune response by commensal gut microbiota and potential new avenues to influence the outcome of allogeneic transplantation by modification of the 'gut culture'.
    Kanangat S
    Int J Immunogenet; 2017 Feb; 44(1):1-6. PubMed ID: 28044415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lymphocytes in transplantation immunity--in the relation to HLA antigens].
    Takata H
    Hum Cell; 1988 Sep; 1(3):275-81. PubMed ID: 2979204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corneal allograft rejection. The role of the major histocompatibility complex.
    Braude LS; Chandler JW
    Surv Ophthalmol; 1983; 27(5):290-305. PubMed ID: 6344291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of CD30 in skin and heart allograft rejection in the mouse.
    Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
    Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
    [No Abstract]   [Full Text] [Related]  

  • 30. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
    Benham AM; Fabre JW
    Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural killer cells, HLA class I molecules, and marrow transplantation.
    Valiante NM; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):229-35. PubMed ID: 9450917
    [No Abstract]   [Full Text] [Related]  

  • 33. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
    Oukka M; Galou M; Belkaid Y; Tricotet V; Riche N; Reynes M; Kosmatopoulos K
    Eur J Immunol; 1997 Dec; 27(12):3499-506. PubMed ID: 9464840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present Yourself! By MHC Class I and MHC Class II Molecules.
    Rock KL; Reits E; Neefjes J
    Trends Immunol; 2016 Nov; 37(11):724-737. PubMed ID: 27614798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cells in allograft rejection.
    Al-Lamki RS; Bradley JR; Pober JS
    Transplantation; 2008 Nov; 86(10):1340-8. PubMed ID: 19034000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Sep; 30(6):2592-3. PubMed ID: 9745505
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect allorecognition is involved in both acute and chronic allograft rejection.
    Fluck N; Witzke O; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366
    [No Abstract]   [Full Text] [Related]  

  • 40. Allorecognition.
    Côté I; Rogers NJ; Lechler RI
    Transfus Clin Biol; 2001 Jun; 8(3):318-23. PubMed ID: 11499986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.